ID   HEV0325
AC   CVCL_T222
DR   RCB; HEV0325
DR   Wikidata; Q54883127
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Korean.
CC   HLA typing: A*11:01,24:02; B*35:01,51:01; C*03:03,15:02; DPB1*02:01,03:01; DQB1*04:01,04:02; DRB1*04:05,04:10 (RCB=HEV0325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa, Mayumi
RA   Goto, Miyako
RA   Noda, Shuhei
RA   Sagara, Masashi
RA   Yamada, Shigeru
RA   Yamamoto, Naoto
RA   Kawakami, Yoshihiro
RA   Matsui, Yoshifumi
RA   Miyazawa, Yukimasa
RA   Yamazaki, Hideya
RA   Tsuji, Hiroshi
RA   Ohno, Tatsuya
RA   Mizoe, Junetsu
RA   Tsujii, Hirohiko
RA   Imai, Takashi
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai, Fumio
RA   Fukushima, Makoto
RA   Miyagi, Yohei
RA   Nakamura, Yukio
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//